Cargando…

Determination of pain and response to methylprednisolone in Guillain-Barré syndrome

Pain can be a serious problem in patients with Guillain-Barré syndrome (GBS). Different pain symptoms and the effect of methylprednisolone on pain are evaluated. METHODS: GBS patients were recruited from a randomized placebo-controlled study comparing intravenous immunoglobulin (IVIg) + methylpredni...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruts, Liselotte, van Koningsveld, Rinske, Jacobs, Bart C., van Doorn, Pieter A.
Formato:	Texto
Lenguaje:	English
Publicado:	Steinkopff-Verlag 2007
Materias:	Original Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2778673/ https://www.ncbi.nlm.nih.gov/pubmed/17426908 http://dx.doi.org/10.1007/s00415-006-0515-2

Ejemplares similares

IVIG Treatment and Prognosis in Guillain–Barré Syndrome
por: van Doorn, Pieter A., et al.
Publicado: (2010)

Tracheostomy or Not: Prediction of Prolonged Mechanical Ventilation in Guillain–Barré Syndrome
por: Walgaard, Christa, et al.
Publicado: (2016)

Hospital Admissions, Transfers and Costs of Guillain-Barré Syndrome
por: van Leeuwen, Nikki, et al.
Publicado: (2016)

IVIg‐induced plasmablasts in patients with Guillain‐Barré syndrome
por: Brem, Maarten D., et al.
Publicado: (2018)

Antibodies to Heteromeric Glycolipid Complexes in Guillain-Barré Syndrome
por: Rinaldi, Simon, et al.
Publicado: (2013)

Diagnosis of Guillain–Barré syndrome in children and validation of the Brighton criteria
por: Roodbol, Joyce, et al.
Publicado: (2017)

Efficient design and analysis of randomized controlled trials in rare neurological diseases: An example in Guillain-Barré syndrome
por: van Leeuwen, Nikki, et al.
Publicado: (2019)

Population Pharmacokinetic Modelling of Intravenous Immunoglobulin Treatment in Patients with Guillain–Barré Syndrome
por: Fokkink, Willem Jan R., et al.
Publicado: (2022)

Changes in motor nerve excitability in acute phase Guillain‐Barré syndrome
por: Drenthen, Judith, et al.
Publicado: (2021)

Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy after alemtuzumab therapy in kidney transplant recipients
por: van der Zwan, Marieke, et al.
Publicado: (2020)

Guillain-Barré syndrome in times of pandemics
por: Leonhard, Sonja E, et al.
Publicado: (2020)

A Comparative Study of IVIG versus IVIG with IV Methylprednisolone in Guillain–Barre Syndrome
por: Bhattiprolu, Rahi Kiran, et al.
Publicado: (2020)

Host Factors Determine Anti-GM1 Response Following Oral Challenge of Chickens with Guillain-Barré Syndrome Derived Campylobacter jejuni Strain GB11
por: Ang, C. Wim, et al.
Publicado: (2010)

Diagnosis and management of Guillain–Barré syndrome in ten steps
por: Leonhard, Sonja E., et al.
Publicado: (2019)

Small volume plasma exchange for Guillain-Barré syndrome in resource poor settings: a safety and feasibility study
por: Islam, Md. Badrul, et al.
Publicado: (2017)

High and Persistent Anti-GM1 Antibody Titers Are Associated With Poor Clinical Recovery in Guillain-Barré Syndrome
por: Thomma, Robin C.M., et al.
Publicado: (2023)

Intravenous immunoglobulin treatment for mild Guillain-Barré syndrome: an international observational study
por: Verboon, Christine, et al.
Publicado: (2021)

Neurofilament light chain as biomarker for axonal damage in Guillain-Barré syndrome
por: Jacobs, Bart C
Publicado: (2021)

Campylobacter jejuni HS:23 and Guillain-Barré Syndrome, Bangladesh
por: Islam, Zhahirul, et al.
Publicado: (2009)

High Incidence of Guillain-Barré Syndrome in Children, Bangladesh
por: Islam, Zhahirul, et al.
Publicado: (2011)

Zika virus and Guillain–Barré syndrome in Bangladesh
por: GeurtsvanKessel, Corine H., et al.
Publicado: (2018)

Prognosis of Guillain–Barré Syndrome Linked to COVID-19 Vaccination
por: Chua, Shaun Kai Kiat, et al.
Publicado: (2022)

Reply to: Comment on: Zika virus and Guillain–Barré syndrome in Bangladesh
por: GeurtsvanKessel, Corine H., et al.
Publicado: (2018)

Fatigue in neuromuscular disorders: focus on Guillain–Barré syndrome and Pompe disease
por: de Vries, J. M., et al.
Publicado: (2009)

Can Campylobacter coli induce Guillain-Barré syndrome?
por: van Belkum, A., et al.
Publicado: (2008)

Guillain–Barré syndrome
por: Mirian, Ario, et al.
Publicado: (2021)

Pain during the acute phase of Guillain–Barré syndrome
por: Yao, Shaoli, et al.
Publicado: (2018)

Guillain-Barré Syndrome Presenting as an Acute Back Pain
por: Hodgeman, Nicholas T, et al.
Publicado: (2021)

Determining the Utility of the Guillain-Barré Syndrome Classification Criteria
por: Tan, Cheng-Yin, et al.
Publicado: (2021)

Guillain-Barré Syndrome in Suriname; Clinical Presentation and Identification of Preceding Infections
por: Langerak, Thomas, et al.
Publicado: (2021)

Small volume plasma exchange for Guillain-Barré syndrome in resource-limited settings: a phase II safety and feasibility study
por: Islam, Badrul, et al.
Publicado: (2018)

COVID-19 and Guillain-Barré syndrome: Response()
por: Camdessanché, Jean-Philippe, et al.
Publicado: (2020)

Hyperreflexic Guillain-Barré syndrome
por: Baheti, Neeraj N., et al.
Publicado: (2010)

An Update in Guillain-Barré Syndrome
por: Winer, J. B.
Publicado: (2014)

Guillain–Barré syndrome mimics
por: Tham, Sai Leong, et al.
Publicado: (2018)

Syndrome de Guillain–Barré
por: Mirian, Ario, et al.
Publicado: (2021)

Guillain-Barré Syndrome after Novel Coronavirus Disease 2019
por: Yakoby, Jordan, et al.
Publicado: (2021)

The clinical features of patients concurrent with Guillain-Barré syndrome and myasthenia gravis
por: Yuan, Junliang, et al.
Publicado: (2018)

Cerebrospinal fluid analysis in Guillain–Barré syndrome: value of albumin quotients
por: Rath, Jakob, et al.
Publicado: (2021)

Guillain–Barré syndrome in low-income and middle-income countries: challenges and prospects
por: Papri, Nowshin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ahh8dek0mvndf7ad42cvmve5pd